Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies (Q37995917)

26 August 2017

Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies (English)

1 reference

26 August 2017

Belma Turan

1

1 reference

PubMed ID

22437738

26 August 2017

Erkan Tuncay

series ordinal

2

1 reference

PubMed ID

22437738

26 August 2017

Guy Vassort

series ordinal

3

1 reference

26 August 2017

1 April 2012

1 reference

Journal of Bioenergetics and Biomembranes

26 August 2017

1 reference

26 August 2017

44

1 reference

26 August 2017

281-296

1 reference

26 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s10863-012-9429-0

26 August 2017

0 references

cites work

Is cardiac hypertrophy in spontaneously hypertensive rats the cause or the consequence of oxidative stress?

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Hyperglycemia adversely modulates endothelial nitric oxide synthase during anesthetic preconditioning through tetrahydrobiopterin- and heat shock protein 90-mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

SirT1 gain of function increases energy efficiency and prevents diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Grapes, wines, resveratrol, and heart health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

SIRT1 transgenic mice show phenotypes resembling calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

A PPARα promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol induces mitochondrial biogenesis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Anti-inflammatory responses of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol and cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Role of AMP-activated protein kinase in healthy and diseased hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Calorie restriction and resveratrol in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol is a class IA phosphoinositide 3-kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol opposite effects on rat tissue lipoperoxidation: pro-oxidant during day-time and antioxidant at night

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Effects of resveratrol and other wine polyphenols on vascular function: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Dietary polyphenols: good, bad, or indifferent for your health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Pharmacological preconditioning with resveratrol: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2·Keap1·Cul3 complex and recruiting Nrf2·Maf to the antioxidant response element enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Preconditioning myocardium with ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol restores lysophosphatidylcholine-induced loss of endothelium-dependent relaxation in rat aorta tissue coinciding with inhibition of extracellular-signal-regulated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Restoration of altered microRNA expression in the ischemic heart with resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Estrogen signaling and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

KATP channels in ischaemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Clinical trials of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol: its biologic targets and functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Sirt1 protects against high-fat diet-induced metabolic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol: one molecule, many targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Therapeutic interventions and oxidative stress in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Central administration of resveratrol improves diet-induced diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Wine, alcohol, platelets, and the French paradox for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Mechanisms underlying vascular effect of chronic resveratrol in streptozotocin-diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

The PGC-1 cascade as a therapeutic target for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Protective effect of resveratrol on acute endotoxemia-induced nephrotoxicity in rat through nitric oxide independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol addiction: to die or not to die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol and health--a comprehensive review of human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol increases vascular oxidative stress resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Red wine triggers cell death and thioredoxin reductase inhibition: effects beyond resveratrol and SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol: a cardioprotective substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Up-regulation of K(+) channels in diabetic rat ventricular myocytes by insulin and glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Doxycycline ameliorates vascular endothelial and contractile dysfunction in the thoracic aorta of diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10863-012-9429-0

Challenges of translating basic research into therapeutics: resveratrol as an example

21 January 2018

1 reference

12 December 2020

Resveratrol in prevention and treatment of common clinical conditions of aging

1 reference

12 December 2020

Resveratrol-induced depression of the mechanical and electrical activities of the rat heart is reversed by glyburide: evidence for possible K(ATP) channels activation

1 reference

12 December 2020

Electrophysiological effects of resveratrol on guinea pig papillary muscles.

1 reference

12 December 2020

Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats

1 reference

12 December 2020

Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4).

1 reference

12 December 2020

Cardioprotection of red wine: role of polyphenolic antioxidants.

1 reference

12 December 2020

AMP-activated protein kinase connects cellular energy metabolism to KATP channel function

1 reference

12 December 2020

Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer

1 reference

12 December 2020

Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress

1 reference

12 December 2020

Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells

1 reference

12 December 2020

Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2

1 reference

12 December 2020

Cardiac dysfunction induced by low and high diet antioxidant levels comparing selenium and vitamin E in rats

1 reference

12 December 2020

Regional differences in the expression of nitric oxide synthase and specific receptors in the vascular tissues of control and diabetic rabbits: a pilot study

1 reference

12 December 2020

Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs

1 reference

12 December 2020

Co-ordinated autophagy with resveratrol and γ-tocotrienol confers synergetic cardioprotection

1 reference

12 December 2020

Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53

1 reference

12 December 2020

Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol

1 reference

12 December 2020

The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury

1 reference

12 December 2020

Oxidative stress in experimental diabetes induced by streptozotocin

1 reference

12 December 2020

Healing the diabetic heart: does myocardial preconditioning work?

1 reference

12 December 2020

Oxidative stress in normal and diabetic rats

1 reference

12 December 2020

10.1007/S10863-012-9429-0

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22437738